H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 51 500 KRW -0.19% Market Closed
Market Cap: 1.5T KRW

HK Inno.N Corp
Short-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

HK Inno.N Corp
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
H
HK Inno.N Corp
KOSDAQ:195940
Short-Term Debt
â‚©250B
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Short-Term Debt
â‚©197.9B
CAGR 3-Years
42%
CAGR 5-Years
44%
CAGR 10-Years
12%
SK Biopharmaceuticals Co Ltd
KRX:326030
Short-Term Debt
â‚©0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Short-Term Debt
â‚©322.5B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
26%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Short-Term Debt
â‚©13.3B
CAGR 3-Years
63%
CAGR 5-Years
36%
CAGR 10-Years
11%
C
Caregen Co Ltd
KOSDAQ:214370
Short-Term Debt
â‚©0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

HK Inno.N Corp
Glance View

Market Cap
1.5T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
67 828.57 KRW
Undervaluation 24%
Intrinsic Value
Price
H

See Also

What is HK Inno.N Corp's Short-Term Debt?
Short-Term Debt
250B KRW

Based on the financial report for Dec 31, 2024, HK Inno.N Corp's Short-Term Debt amounts to 250B KRW.

What is HK Inno.N Corp's Short-Term Debt growth rate?
Short-Term Debt CAGR 3Y
33%

Over the last year, the Short-Term Debt growth was 5%. The average annual Short-Term Debt growth rates for HK Inno.N Corp have been 33% over the past three years .

Back to Top